Leukemia & Lymphoma, Volume 63, Issue 10 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 63, Issue 10 (2022)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Volume 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article Commentary
CAR T-cells in relapsed Burkitt lymphoma – a promising test drive in a rare disease
J. Erika Haydu & Jeremy S. Abramson
Pages: 2263-2264
Published online: 20 Jul 2022
CitationforCAR T-cells in relapsed Burkitt lymphoma – a promising test drive in a rare disease | Full Text | References | PDF (344.9 KB) | EPUB
  • 203 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review
CD38 as a multifaceted immunotherapeutic target in CLL
Aneel Paulus, Fabio Malavasi & Asher Chanan-Khan
Pages: 2265-2275
Published online: 17 Aug 2022
AbstractforCD38 as a multifaceted immunotherapeutic target in CLL | Full Text | References | PDF (1.4 MB) | EPUB
  • 289 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group
Doreen G. Te Raa, Lina van der Straten, Michel van Gelder, Sabina Kersting, Mark-David Levin, Rogier Mous, Hanneke M. van der Straaten, Marten R. Nijziel, Ellen van der Spek, Eduardus F. M Posthuma, Hein P.J Visser, Marjolein van der Klift, Koen de Heer, Mar Bellido, Jeanette K. Doorduijn, Anke H.W Bruns, Reinier A. P Raijmakers, Arnon P. Kater & HOVON CLL study group
Pages: 2276-2289
Published online: 23 Jun 2022
AbstractforDiagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 396 Views
  • 1 CrossRef citations
  • 0Altmetric

Articles

Article
Factors associated with risk and prognosis of intensive care unit admission in patients with acute leukemia: a Danish nationwide cohort study
Cecilie Velsoe Maeng, Christian Fynbo Christiansen, Kathleen Dori Liu, Peter Kamper, Steffen Christensen, Bruno C. Medeiros & Lene Sofie Granfeldt Østgård
Pages: 2290-2300
Published online: 18 May 2022
AbstractforFactors associated with risk and prognosis of intensive care unit admission in patients with acute leukemia: a Danish nationwide cohort study | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 1277 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome
Xiaodong Lyu, Tao Li, Dandan Zhu, Yuexin Cheng, Yan Chen, Xiangxiang He, Zhenling Li, Shiyong Li, Wei Wu, Shuaipeng Geng, Mengna Zhang, Chunxiao Yao, Jingshuai Li, Yangwei Li, Yinyin Chang, Yuchun Li, Zunmin Zhu, Mao Mao & Yongping Song
Pages: 2301-2310
Published online: 11 Jun 2022
AbstractforWhole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome | Full Text | References | PDF (2.5 MB) | EPUB | Supplemental
  • 284 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium
Marie Engvall, Ylva Karlsson, Ekaterina Kuchinskaya, Åsa Jörnegren, Lucy Mathot, Tatjana Pandzic, Josefine Palle, Viktor Ljungström, Lucia Cavelier, Eva Hellström Lindberg, Jörg Cammenga & Panagiotis Baliakas
Pages: 2311-2320
Published online: 09 May 2022
AbstractforFamilial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 1259 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing
Jing Xu, Zhuanghui Hao, Xian Chen, Minglin Hong, Daniel muteb Muyey, Xiuhua Chen & Hongwei Wang
Pages: 2321-2329
Published online: 02 Jun 2022
AbstractforThe characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 211 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemia
Sigrid Machherndl-Spandl, Thomas Vockenhuber, Michaela Binder, Ansgar Weltermann, Petra Apfalter, Cornelia Lass-Flörl & Michael Girschikofsky
Pages: 2330-2335
Published online: 13 May 2022
AbstractforEfficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemia | Full Text | References | PDF (711.1 KB) | EPUB
  • 264 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Predictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis
Chaolu Hu & Xiaoqin Wang
Pages: 2336-2351
Published online: 11 May 2022
AbstractforPredictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis | Full Text | References | PDF (3.8 MB) | EPUB | Supplemental
  • 140 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Lower tumor burden is associated with better cognitive function in patients with chronic phase chronic myeloid leukemia
Zongru Li, Li Peng, Yongjie Li, Jun Zhang & Qian Jiang
Pages: 2352-2363
Published online: 11 May 2022
AbstractforLower tumor burden is associated with better cognitive function in patients with chronic phase chronic myeloid leukemia | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 141 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy
Adam H. Lapidus, Mary Ann Anderson, Simon J. Harrison, Michael Dickinson, Tomas Kalincik & Arian Lasocki
Pages: 2364-2374
Published online: 14 May 2022
AbstractforNeuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 482 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Toxicity associated with high-dose intravenous methotrexate for hematological malignancies
Joel Wight, Matthew Ku, Melissa Garwood, Duncan Carradice, Masa Lasica, Louise Keamy, Eliza A. Hawkes & Andrew Grigg
Pages: 2375-2382
Published online: 16 May 2022
AbstractforToxicity associated with high-dose intravenous methotrexate for hematological malignancies | Full Text | References | PDF (1.2 MB) | EPUB
  • 407 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study
Habte Yimer, Jason Melear, Edward Faber, William I. Bensinger, John M. Burke, Mohit Narang, Don Stevens, Kathleen S. Gray, Yana Lutska, Padma Bobba, Keqin Qi, Daniela Hoehn, Ming Qi, Thomas S. Lin & Robert M. Rifkin
Pages: 2383-2392
Published online: 22 Jun 2022
AbstractforDaratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study | Full Text | References | PDF (988.5 KB) | EPUB | Supplemental
  • 4204 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents
Anna Bögelein, Antje Stolzenburg, Patrick Eiring, Katharina Lückerath, Umair Munawar, Rudolf Werner, Andreas Schirbel, Samuel Samnick, Klaus Martin Kortüm, Markus Sauer, Constantin Lapa & Andreas K. Buck
Pages: 2393-2402
Published online: 08 Jul 2022
AbstractforCXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 248 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma
Matthew Ho, Maria Moscvin, Soon Khai Low, Benjamin Evans, Sara Close, Robert Schlossman, Jacob Laubach, Claudia Paba Prada, Brett Glotzbecker, Paul G. Richardson & Giada Bianchi
Pages: 2403-2412
Published online: 14 Jun 2022
AbstractforRisk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 254 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies
Ola Landgren, Dickran Kazandjian, Murielle Roussel, Jagoda Jasielec, Dominik Dytfeld, Aparna Anderson, Tara A. Kervin, Karim Iskander, Ian McFadden & Andrzej J. Jakubowiak
Pages: 2413-2421
Published online: 12 May 2022
AbstractforEfficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 318 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation
Morie A. Gertz, Rahma Warsame, Eli Muchtar, Frances Buadi, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Suzanne Hayman, Prashant Kapoor, Taxiarchis Kourelis, Shaji K. Kumar, Martha Q. Lacy & William Hogan
Pages: 2422-2427
Published online: 12 May 2022
AbstractforLack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation | Full Text | References | PDF (1.1 MB) | EPUB
  • 156 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study
Matthew W. Parsons, David A. Wada, Ahmad S. Halwani, Randa Tao & David K. Gaffney
Pages: 2428-2435
Published online: 24 Jun 2022
AbstractforImproved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 164 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Impact of autograft-absolute lymphocyte count on survival in double/triple hit lymphomas post-autologous stem cell transplantation
Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo & Svetomir N. Markovic
Pages: 2436-2443
Published online: 28 Apr 2022
AbstractforImpact of autograft-absolute lymphocyte count on survival in double/triple hit lymphomas post-autologous stem cell transplantation | Full Text | References | PDF (1.3 MB) | EPUB
  • 154 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant
Robert Puckrin, Neil Chua, Mona Shafey & Douglas A. Stewart
Pages: 2444-2452
Published online: 22 Apr 2022
AbstractforImproving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant | Full Text | References | PDF (1,011.9 KB) | EPUB | Supplemental
  • 352 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
TCF3 protein was highly expressed in pediatric Burkitt lymphoma and predicts poor prognosis: a single-center study
Jie Man, Hongsheng Wang, Xiaowen Qian, Lian Chen, Yangyang Ma, Maoxiang Qian & Xiaowen Zhai
Pages: 2453-2460
Published online: 26 May 2022
AbstractforTCF3 protein was highly expressed in pediatric Burkitt lymphoma and predicts poor prognosis: a single-center study | Full Text | References | PDF (1.5 MB) | EPUB
  • 178 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective study
Tamar Berger, Karyn Revital Geiger, Moshe Yeshurun, Anat Gafter‑Gvili, Tzippy Shochat, Ronit Gurion, Pia Raanani & Oren Pasvolsky
Pages: 2461-2468
Published online: 28 May 2022
AbstractforRepeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective study | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 114 Views
  • 0 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience
Samantha J. Seitter, Paul H. McClelland, Mark A. Ahlman, Stephanie L. Goff, James C. Yang, Lori McIntyre, Steven A. Rosenberg, James N. Kochenderfer & Jennifer N. Brudno
Pages: 2469-2473
Published online: 09 Jun 2022
First Page PreviewforDurable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience | Full Text | References | PDF (884.3 KB) | EPUB
  • 539 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
The frequency, hematological characteristics, and end-of induction residual disease in B-acute lymphoblastic leukemia with BCR-ABL1-like chimeric gene fusions in a high-risk cohort from India
Praveen Sharma, Sonia Rana, Harpreet Virk, Man Updesh Singh Sachdeva, Prashant Sharma, Neelam Varma, Richa Jain, Deepak Bansal, Amita Trehan, Alka Rani Khadwal, Pankaj Malhotra & Sreejesh Sreedharanunni
Pages: 2474-2478
Published online: 24 May 2021
First Page PreviewforThe frequency, hematological characteristics, and end-of induction residual disease in B-acute lymphoblastic leukemia with BCR-ABL1-like chimeric gene fusions in a high-risk cohort from India | Full Text | References | PDF (1.1 MB) | EPUB
  • 204 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Rare case of leptomeningeal small lymphocytic lymphoma with TP53 mutation detected by deep next-generation sequencing
Mark G. Evans, Anna Shestakova, Nahideh Haghighi, Xiaohui Zhao, Valentina Nardi, Lauren C. Pinter-Brown & Sherif A. Rezk
Pages: 2479-2483
Published online: 03 May 2022
AbstractforRare case of leptomeningeal small lymphocytic lymphoma with TP53 mutation detected by deep next-generation sequencing | Full Text | References | PDF (1.6 MB) | EPUB
  • 254 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination
Lauren C. Shapiro, Astha Thakkar, Radhika Gali, Jesus D. Gonzalez-Lugo, Abdul-Hamid Bazarbachi, Shafia Rahman, Kith Pradhan, Karen Fehn, Michelly Abreu, Noah Kornblum, Kira Gritsman, Mendel Goldfinger, Aditi Shastri, Ioannis Mantzaris, Ira Braunschweig, Balazs Halmos, Amit Verma, Margaret McCort, Lizamarie Bachier-Rodriguez & R. Alejandro Sica
Pages: 2484-2488
Published online: 20 May 2022
First Page PreviewforHigh seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination | Full Text | References | PDF (638.8 KB) | EPUB
  • 147 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination
Lara Howells, Wei Yee Chan, Emilie Sanchez, Jacqueline Horder, Fiona Newrick, Jotham Marfil, Annabel McMillan, Brendan Wisniowski, Shameem Mahmood, Xenofon Papanikolaou, Lydia Lee, Ashutosh Wechalekar, Rakesh Popat, Jonathan Sive, Charalampia Kyriakou, Ke Xu, Eleni Nastouli, Kwee L. Yong & Neil Rabin
Pages: 2489-2493
Published online: 14 May 2022
First Page PreviewforPatients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination | Full Text | References | PDF (1,023 KB) | EPUB | Supplemental
  • 121 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Transplantation provides superior survival high risk myeloid malignancies in older patients
Celalettin Ustun, Erica Warlick, Sunita Nathan, Linda J. Burns & Daniel Weisdorf
Pages: 2494-2498
Published online: 19 May 2022
First Page PreviewforTransplantation provides superior survival high risk myeloid malignancies in older patients | Full Text | References | PDF (741.8 KB) | EPUB | Supplemental
  • 59 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome
Ayaka Sakaki, Hiroki Hosoi, Hideki Kosako, Yoshiaki Furuya, Ryuta Iwamoto, Takayuki Hiroi, Shogo Murata, Toshiki Mushino, Shin-Ichi Murata & Takashi Sonoki
Pages: 2499-2502
Published online: 13 May 2022
First Page PreviewforSuccessful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome | Full Text | References | PDF (962.2 KB) | EPUB
  • 232 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma
Qingyuan Zhang, Rong Tao, Zhenyu Li, Haiyi Guo, Meng Ji, Lu Zhang, Jane Huang, Fu Lina, Jinhua Zhong & Jianfeng Zhou
Pages: 2503-2506
Published online: 19 Jul 2022
First Page PreviewforA phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma | Full Text | References | PDF (550.1 KB) | EPUB | Supplemental
  • 242 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Differential use of the hematopoietic cell transplantation-comorbidity index among adult and pediatric transplant physicians
Larisa Broglie, Brian D. Friend, Saurabh Chhabra, Caitrin Bupp, Gary J. Schiller, Brent Logan, Marcelo C. Pasquini, Bipin Savani, Edward A. Stadtmauer, Monica S. Thakar & Mohamed Sorror
Pages: 2507-2510
Published online: 18 May 2022
First Page PreviewforDifferential use of the hematopoietic cell transplantation-comorbidity index among adult and pediatric transplant physicians | Full Text | References | PDF (720.8 KB) | EPUB
  • 108 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Bing-Neel syndrome coexisting with oligodendroglioma
Livia Donzelli, Clara Minotti, Giovanni Fernando Torelli, Claudio Cartoni, Cristina Luise, Alice Di Rocco, Luigi Petrucci, Arianna Di Napoli & Maurizio Martelli
Pages: 2511-2514
Published online: 19 May 2022
First Page PreviewforBing-Neel syndrome coexisting with oligodendroglioma | Full Text | References | PDF (1,000.6 KB) | EPUB
  • 65 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles